Dr. Mehling, of West Islip, N.Y.-based Mehling Orthopedics, is an alumnus of Wright State University Boonshoft School of Medicine. He is also CMO of Blue Horizon International, a healthcare consulting company that provides stem cell therapies to emerging markets and charity care to the underserved. His presentation focused on the use of stem cells in treating chronic inflammation symptoms.
“Stem cells are the future of medicine and we believe their role in treatments will become the preferred substitutes for many surgical, pharmacological and rehabilitative medical services,” said Dr. Mehling.
At the Becker’s 32nd Annual Meeting: The Business and Operations of ASCs, taking place October 29-31 in Chicago, ASC leaders, surgeons and healthcare executives will explore strategies to drive growth, enhance operational performance, navigate reimbursement challenges and prepare for the future of ambulatory surgery. Apply for complimentary registration now.